Sanjay Chhabria

SEBI regd. RA(INH000001592), Small-Midcaps. Disciplined Investing+Asset Allocation+ Long term Horizon = Wealth creation. DM for paid services.

[Sanjay Chhabria @Sanjay_Chhabria]

My Diwali Picks 2025-
HDB Financial Services(Rs 730)
MPS(Rs 2295)
Signpost India(Rs 239)
Nuvoco Vistas Corporation(Rs 411)
International Gemmological Institute(Rs 336)
Uniparts India(Rs 526)
Not a reco. Do your own research.
Retweet max to get reports on any of the above two stocks in your mail id.

[Sanjay Chhabria @Sanjay_Chhabria]

@SushantBSinha Heartiest Birthday Wishes.

[Sanjay Chhabria @Sanjay_Chhabria]

@volklub Happy Holidays

[Sanjay Chhabria @Sanjay_Chhabria]

@Riddhishree27 Heartiest Birthday wishes

[Sanjay Chhabria @Sanjay_Chhabria]

@SahilKapoor Wonderful. Rare to find such kids nowadays.

[Sanjay Chhabria @Sanjay_Chhabria]

@SahilKapoor Die with Zero- Bill Perkins

[Sanjay Chhabria @Sanjay_Chhabria]

@NR1ne @kapil_tandon Heartiest Birthday Wishes Sir ji @kapil_tandon

[Nalini Unagar @NalinisKitchen]

Hate India as much as you want, but you can’t ignore the fact that medical facilities in India are very easily accessible.

Left:
A lady named Victoria needed medicine, but her health insurance company refused to cover the expense, and the medicine cost $1,000. She then ordered it from India, where it cost only $10 + $15 shipping, so it cost her just $25.

Right:
Lia, a European traveller, said that in many countries, blood tests require appointments that take many days. But in India, I was able to get a blood test very easily, and within 24 hours I received my test report on WhatsApp.

This is a very positive aspect of India.

[Sanjay Chhabria @Sanjay_Chhabria]

@TrendonomicsHD Much bad advice is given free - Benjamin Graham

[Sanjay Chhabria @Sanjay_Chhabria]

@Iamsamirarora Much bad advice is given free - Benjamin Graham

[Sanjay Chhabria @Sanjay_Chhabria]

@Sahilpahwa09 Happy Birthday

[Sanjay Chhabria @Sanjay_Chhabria]

Know a Company- Procter & Gamble Health Ltd.(PGH)(Rs 5,126)(Market Cap- 8,510 cr.) is one of India’s largest vitamins, minerals, and supplements (VMS) companies manufacturing and marketing VMS products for a healthy lifestyle and improved quality of life. It has a strong portfolio of various pharma brands such as Evion, Neurobion, Seven seas, Nasivion, Polybion, Cosome, and Livogen.

PGH’s strategy, centered on a focused portfolio of quality, trusted, and highly recommended brands where performance drives brand choice; superiority (across product, package, brand communication, retail execution and value), constructive disruption and an agile accountable organization, is delivering balanced and sustainable growth results.

At Rs 5,126, the PGH stock trades at 24 times FY27E earnings. PGH had declared a interim dividend of Rs 160 per share in February 2026.

9MFY26- Revenues up 14% to Rs 1,037 cr., Net Profit up 22% to Rs 232.3 cr., EPS-Rs 140 , Equity- Rs 16.6 cr.

The above is just for information and not a recommendation

[Sanjay Chhabria @Sanjay_Chhabria]

@nid_rockz Belated Birthday wishes. Have a wonderful year ahead.

[Sanjay Chhabria @Sanjay_Chhabria]

Know a Company- Procter & Gamble Health Ltd.(PGH)(Rs 5,126)(Market Cap- 8,510 cr.) is one of India’s largest vitamins, minerals, and supplements (VMS) companies manufacturing and marketing VMS products for a healthy lifestyle and improved quality of life. It has a strong portfolio of various pharma brands such as Evion, Neurobion, Seven seas, Nasivion, Polybion, Cosome, and Livogen.

PGH’s strategy, centered on a focused portfolio of quality, trusted, and highly recommended brands where performance drives brand choice; superiority (across product, package, brand communication, retail execution and value), constructive disruption and an agile accountable organization, is delivering balanced and sustainable growth results.

At Rs 5,126, the PGH stock trades at 24 times FY27E earnings. PGH had declared a interim dividend of Rs 160 per share in February 2026.

9MFY26- Revenues up 14% to Rs 1,037 cr., Net Profit up 22% to Rs 232.3 cr., EPS-Rs 140 , Equity- Rs 16.6 cr.

The above is just for information and not a recommendation

[Sanjay Chhabria @Sanjay_Chhabria]

@drmohanv Belated birthday wishes Sir. Have a wonderful year ahead.

[Sanjay Chhabria @Sanjay_Chhabria]

Know a Company- Blackstone-promoted International Gemmological Institute (IGI)(Rs 320)(Rs 2 paid up)(Mcap-13,835 cr.) is India's largest and world's second largest certification provider for gems and jewellery. IGI has 50% market share in India and 33% global market share. IGI, a certification and accreditation company, grades and certifies diamonds, coloured stones and studded jewellery. The certification market has high entry barriers - players need to build up trust, bear infrastructure costs, acquire and retain skilled labour, and develop strategic retail partnerships.

The business is highly profitable, asset light, and generates high cashflows. IGI had come with an IPO at Rs 417 per share in December 2024.

With 31 laboratories and 18 Schools of Gemology in 10 countries, IGI's global presence enables it to capitalize on the ongoing transformation in the industry. By continuing to embrace innovation and expanding its global footprint, IGI is well-positioned to capitalize on emerging opportunities and reinforce its position as the preferred certification partner for the jewelry industry. At Rs 320, the IGI stock trades at 21 times CY26E earnings.

CY25- Revenues up 17% to Rs 1,229 cr., Net Profit up 24% to Rs 531.6 cr., EPS-Rs 12.30 , Equity- Rs 86.43 cr.

[Sanjay Chhabria @Sanjay_Chhabria]

@sainik636 @DC_aryavarta Grateful to Chaturvedi Sir ji

[Sanjay Chhabria @Sanjay_Chhabria]

Know a Company- Automobile Corporation of Goa Ltd(ACGL)(Rs 1,454) (Mcap -884 cr.), is jointly promoted by Tata Motors(TML) (Stake- 48.98%) and EDC (formerly known as Economic Development Corporation of Goa, Daman & Diu) in 1980. ACGL enjoys strong operational linkages with TML, being one of its leading suppliers for bus body requirements, contributing 45-50% of TML’s ICE bus body needs. ACGL engages in the manufacturing and sale of sheet metal components and bus bodies, with the majority of its revenue coming from the bus body building division.
In FY25, ACGL's Total Revenue increased by 14% to ₹651.11 cr., driven by improved sales realisations, higher volumes, and better capacity utilisation. The company achieved its highest-ever bus sales, marking a strong performance. At Rs 1,454, the ACGL share trades at 14 times FY26E earnings.

9MFY26- Revenues- 652 cr., Net Profit – 48.56 cr., EPS-Rs 80 , Equity- Rs 6.08 cr.

[Sanjay Chhabria @Sanjay_Chhabria]

@SahilKapoor Looking forward to it as always.